G.Q. Yang

551 total citations
34 papers, 350 citations indexed

About

G.Q. Yang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, G.Q. Yang has authored 34 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 9 papers in Otorhinolaryngology. Recurrent topics in G.Q. Yang's work include Head and Neck Cancer Studies (9 papers), Sarcoma Diagnosis and Treatment (8 papers) and Vascular Tumors and Angiosarcomas (5 papers). G.Q. Yang is often cited by papers focused on Head and Neck Cancer Studies (9 papers), Sarcoma Diagnosis and Treatment (8 papers) and Vascular Tumors and Angiosarcomas (5 papers). G.Q. Yang collaborates with scholars based in United States. G.Q. Yang's co-authors include Daniel Oliver, A.O. Naghavi, Kamran A. Ahmed, Russell F. Palm, Peter A.S. Johnstone, Y.A. Abuodeh, Ankur R. Sangoi, Bijayee Shrestha, Andrew H. Beck and Casey Liveringhouse and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

G.Q. Yang

30 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G.Q. Yang United States 8 205 159 68 63 62 34 350
Mukta Ramadwar India 14 130 0.6× 169 1.1× 32 0.5× 154 2.4× 69 1.1× 45 386
L. Pétriz Spain 8 145 0.7× 90 0.6× 38 0.6× 67 1.1× 108 1.7× 12 334
Toshiko Sakuma Japan 13 274 1.3× 234 1.5× 73 1.1× 87 1.4× 21 0.3× 36 523
Melis Gültekin Türkiye 11 105 0.5× 118 0.7× 68 1.0× 171 2.7× 26 0.4× 75 487
K. Khanfir Switzerland 11 155 0.8× 214 1.3× 22 0.3× 185 2.9× 96 1.5× 23 404
Paolo Antognoni Italy 14 151 0.7× 257 1.6× 61 0.9× 394 6.3× 66 1.1× 32 646
Robin Schoenthaler United States 8 228 1.1× 124 0.8× 80 1.2× 155 2.5× 50 0.8× 12 388
Alexandra Jensen Germany 9 136 0.7× 129 0.8× 37 0.5× 133 2.1× 70 1.1× 12 428
Kristie J. Paris United States 12 188 0.9× 137 0.9× 71 1.0× 275 4.4× 28 0.5× 28 470
Seog-Yun Park South Korea 10 172 0.8× 170 1.1× 75 1.1× 72 1.1× 34 0.5× 22 433

Countries citing papers authored by G.Q. Yang

Since Specialization
Citations

This map shows the geographic impact of G.Q. Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.Q. Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.Q. Yang more than expected).

Fields of papers citing papers by G.Q. Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G.Q. Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.Q. Yang. The network helps show where G.Q. Yang may publish in the future.

Co-authorship network of co-authors of G.Q. Yang

This figure shows the co-authorship network connecting the top 25 collaborators of G.Q. Yang. A scholar is included among the top collaborators of G.Q. Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G.Q. Yang. G.Q. Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nasser, Nicola J., G.Q. Yang, Eduardo G. Moros, Jimmy J. Caudell, & Gage Redler. (2024). Dosimetric Evaluation of PTV Margin Reduction for Online Adaptive Radiotherapy in Head and Neck Cancer Sequential Boost Treatments. International Journal of Radiation Oncology*Biology*Physics. 120(2). e169–e170.
2.
Johnston, Fabian M., Ana P. Kiess, Kedar Kirtane, et al.. (2024). The History and Future of Multidisciplinary Cancer Care. Seminars in Radiation Oncology. 34(4). 441–451. 1 indexed citations
3.
Shen, Colette J., Jessica M. Frakes, Trevor Hackman, et al.. (2024). Early signs of efficacy in patients with anti-PD-1 naïve and anti-PD-1 resistant HNSCC treated with NBTXR3/SBRT in combination with nivolumab or pembrolizumab in the phase I trial Study 1100.. Journal of Clinical Oncology. 42(16_suppl). 6035–6035. 3 indexed citations
4.
Bryant, John Michael, Matthew N. Mills, G.Q. Yang, et al.. (2024). Novel Definitive Hypofractionated Accelerated Radiation Dose-painting (HARD) for Unresected Soft Tissue Sarcomas. Advances in Radiation Oncology. 9(4). 101447–101447. 2 indexed citations
5.
Bryant, John Michael, Matthew N. Mills, Casey Liveringhouse, et al.. (2024). Hypofractionated accelerated radiation dose-painting (HARD) improves outcomes in unresected soft-tissue sarcoma. Radiotherapy and Oncology. 202. 110644–110644. 1 indexed citations
6.
Zahid, Mohammad U., et al.. (2023). Proliferation Saturation Index to Simulate Adaptive Radiation Fractionation in HPV-Associated Oropharyngeal Cancer. International Journal of Radiation Oncology*Biology*Physics. 117(2). e495–e496. 2 indexed citations
7.
Yang, G.Q., et al.. (2023). A head and neck treatment planning strategy for a CBCT‐guided ring‐gantry online adaptive radiotherapy system. Journal of Applied Clinical Medical Physics. 24(12). e14134–e14134. 9 indexed citations
8.
Mills, Matthew N., Casey Liveringhouse, John Michael Bryant, et al.. (2023). Novel Postoperative Hypofractionated Accelerated Radiation Dose-Painting Approach for Soft Tissue Sarcoma. Advances in Radiation Oncology. 9(3). 101391–101391. 4 indexed citations
9.
Liveringhouse, Casey, Russell F. Palm, John Michael Bryant, et al.. (2023). Neoadjuvant Simultaneous Integrated Boost Radiation Therapy Improves Clinical Outcomes for Retroperitoneal Sarcoma. International Journal of Radiation Oncology*Biology*Physics. 117(1). 123–138. 7 indexed citations
10.
Echevarria, Michelle, G.Q. Yang, Dung‐Tsa Chen, et al.. (2023). Phase 1 Dose Escalation of Stereotactic Body Radiation Therapy and Concurrent Cisplatin for Reirradiation of Unresectable, Recurrent Squamous Cell Carcinoma of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics. 117(2). 341–347. 7 indexed citations
11.
Palm, Russell F., Casey Liveringhouse, Ricardo González, et al.. (2022). Effect of Favorable Pathologic Response After Neoadjuvant Radiation Therapy Alone in Soft-tissue Sarcoma. Advances in Radiation Oncology. 8(1). 101086–101086. 5 indexed citations
12.
Yang, G.Q., Zhigang Yuan, Kamran A. Ahmed, et al.. (2021). Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization. Translational Oncology. 14(10). 101165–101165. 34 indexed citations
13.
Yang, G.Q., Matthew N. Mills, Youngchul Kim, et al.. (2020). Enhancement of the Follicular Lymphoma International Prognostic Index (FLIPI) with lymphopenia (FLIPI-L): a predictor for overall survival and histologic transformation. Blood Cancer Journal. 9(12). 104–104. 11 indexed citations
14.
Parekh, Akash D., et al.. (2020). Nonclinical Time in U.S. Radiation Oncology Residency Programs: Number of Months and Resident Opinion of Value. International Journal of Radiation Oncology*Biology*Physics. 106(4). 683–689. 5 indexed citations
15.
Yuan, Zhigang, G.Q. Yang, Kamran Ahmed, et al.. (2020). Radiation therapy in the management of the inguinal region in penile cancer: What's the evidence?. Urologic Oncology Seminars and Original Investigations. 40(6). 223–228. 4 indexed citations
16.
Oliver, Daniel, G. Daniel Grass, A.O. Naghavi, et al.. (2018). Extracranial metastatic burden in extensive-stage small cell lung cancer: implications for prophylactic cranial irradiation. Journal of Thoracic Disease. 10(7). 4321–4327. 5 indexed citations
17.
Yang, G.Q., et al.. (2018). De-escalation of Primary Target and Elective Neck Doses in HPV-Positive Oropharyngeal Cancers. International Journal of Radiation Oncology*Biology*Physics. 100(5). 1326–1327. 2 indexed citations
18.
Mills, Matthew N., G.Q. Yang, Daniel Oliver, et al.. (2018). Histologic heterogeneity of triple negative breast cancer: A National Cancer Centre Database analysis. European Journal of Cancer. 98. 48–58. 62 indexed citations
19.
Yuan, Zhigang, Kamran A. Ahmed, G. Daniel Grass, et al.. (2017). Radiotherapy Rescue of a Nivolumab-Refractory Immune Response in a Patient with PD-L1–Negative Metastatic Squamous Cell Carcinoma of the Lung. Journal of Thoracic Oncology. 12(9). e135–e136. 42 indexed citations
20.
Parthan, Anju, et al.. (2011). PMD21 IS CYBERKNIFE A COST-EFFECTIVE OPTION FOR TREATING PROSTATE CANCER?. Value in Health. 14(3). A82–A83.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026